top of page
Registrations are Closed
Dr. Siuli Mitra
Acting Director
India Bioscience
Join us at NCURB for a Career Talk with Dr. Siuli Mitra, Acting Director at IndiaBioscience! This Career Insights Session will explore diverse pathways in science including academia, industry, startups, policy and more while offering practical guidance on navigating challenges and shaping your future.
Dr. Sanhita Sinharay
Assistant Professor
Department of Bioengineering
IISc Bangalore
Dr. Sanhita's lab discovers, validates and translates molecular imaging biomarkers that can non-invasively assess disease load and response to therapeutics at early stages. Her work spans the domains of biochemistry, molecular biology and chemistry.
Dr. Nandini Rajamani
Associate Professor
Department of Biology
IISER Tirupati
Dr. Nandini's research uncovers the evolutionary reasons for diversity in morphological and behavioral traits across related species, and how local adaptations are impacted by anthropogenic and climate change. The Sciurid lab employs non-model organisms like squirrels and pikas through a combination of field, lab, and computational techniques.
Prof. Divya Chandran
Professor
Department of Plant Biotechnology
Regional Centre for Biotechnology
Prof. Divya's lab uncovers the molecular and genetic pathways that enable leguminous crops defend themselves against a destructive fungal disease. Her research paves the way to developing strategies for disease resistant crops and improved food security.
Dr. Raju Mukherjee
Associate Professor
Department of Biology
IISER Tirupati
Dr. Mukherjee’s research explores how bacteria like Mycobacterium tuberculosis survive potent drugs, uncovering the mechanisms behind their resistance. Using approaches such as proteomics and genome-wide mutagenesis, his work identifies bacterial vulnerabilities, paving the way for better therapeutic interventions and effective treatments.
Dr. Monalisa Chatterji
Co-Founder
Sekkei Bio Pvt. Ltd.
Dr. Monalisa Chatterji leads the team at Sekkei Bio that's reimagining how new medicines are built.
Her team is working on next-gen approaches reshaping drug design, like circular RNA therapeutics and optimization of oral peptide therapeutics.
They combine computer-based research and lab experiments to develop new kinds of treatments, and to make advanced healthcare more affordable, effective, and accessible for everyone.
bottom of page